MiMedx Group Statistics
Total Valuation
MiMedx Group has a market cap or net worth of $1.36 billion. The enterprise value is $1.26 billion.
Important Dates
The last earnings date was Wednesday, October 30, 2024, after market close.
Earnings Date | Oct 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MiMedx Group has 146.95 million shares outstanding. The number of shares has increased by 47.75% in one year.
Current Share Class | 146.95M |
Shares Outstanding | 146.95M |
Shares Change (YoY) | +47.75% |
Shares Change (QoQ) | -0.35% |
Owned by Insiders (%) | 1.42% |
Owned by Institutions (%) | 42.84% |
Float | 108.98M |
Valuation Ratios
The trailing PE ratio is 17.88 and the forward PE ratio is 31.69.
PE Ratio | 17.88 |
Forward PE | 31.69 |
PS Ratio | 3.70 |
Forward PS | 3.52 |
PB Ratio | 7.36 |
P/TBV Ratio | 9.07 |
P/FCF Ratio | 24.43 |
P/OCF Ratio | 23.64 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 18.69, with an EV/FCF ratio of 22.60.
EV / Earnings | 15.38 |
EV / Sales | 3.68 |
EV / EBITDA | 18.69 |
EV / EBIT | 19.82 |
EV / FCF | 22.60 |
Financial Position
The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.11.
Current Ratio | 4.10 |
Quick Ratio | 3.41 |
Debt / Equity | 0.11 |
Debt / EBITDA | 0.28 |
Debt / FCF | 0.34 |
Interest Coverage | 19.66 |
Financial Efficiency
Return on equity (ROE) is 62.47% and return on invested capital (ROIC) is 23.08%.
Return on Equity (ROE) | 62.47% |
Return on Assets (ROA) | 18.38% |
Return on Capital (ROIC) | 23.08% |
Revenue Per Employee | $383,021 |
Profits Per Employee | $91,619 |
Employee Count | 895 |
Asset Turnover | 1.58 |
Inventory Turnover | 2.63 |
Taxes
Income Tax | -25.89M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.33% in the last 52 weeks. The beta is 1.94, so MiMedx Group's price volatility has been higher than the market average.
Beta (5Y) | 1.94 |
52-Week Price Change | +28.33% |
50-Day Moving Average | 6.48 |
200-Day Moving Average | 7.01 |
Relative Strength Index (RSI) | 78.62 |
Average Volume (20 Days) | 1,137,216 |
Short Selling Information
The latest short interest is 4.00 million, so 2.72% of the outstanding shares have been sold short.
Short Interest | 4.00M |
Short Previous Month | 4.03M |
Short % of Shares Out | 2.72% |
Short % of Float | 3.67% |
Short Ratio (days to cover) | 8.91 |
Income Statement
In the last 12 months, MiMedx Group had revenue of $342.80 million and earned $82.00 million in profits. Earnings per share was $0.52.
Revenue | 342.80M |
Gross Profit | 285.80M |
Operating Income | 63.65M |
Pretax Income | 63.47M |
Net Income | 82.00M |
EBITDA | 67.51M |
EBIT | 63.65M |
Earnings Per Share (EPS) | $0.52 |
Full Income Statement Balance Sheet
The company has $88.80 million in cash and $19.02 million in debt, giving a net cash position of $69.78 million or $0.47 per share.
Cash & Cash Equivalents | 88.80M |
Total Debt | 19.02M |
Net Cash | 69.78M |
Net Cash Per Share | $0.47 |
Equity (Book Value) | 181.01M |
Book Value Per Share | 1.23 |
Working Capital | 130.20M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $57.67 million and capital expenditures -$1.85 million, giving a free cash flow of $55.83 million.
Operating Cash Flow | 57.67M |
Capital Expenditures | -1.85M |
Free Cash Flow | 55.83M |
FCF Per Share | $0.38 |
Full Cash Flow Statement Margins
Gross margin is 83.37%, with operating and profit margins of 18.57% and 25.80%.
Gross Margin | 83.37% |
Operating Margin | 18.57% |
Pretax Margin | 17.49% |
Profit Margin | 25.80% |
EBITDA Margin | 19.69% |
EBIT Margin | 18.57% |
FCF Margin | 14.26% |
Dividends & Yields
MiMedx Group does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -47.75% |
Shareholder Yield | -47.75% |
Earnings Yield | 6.01% |
FCF Yield | 4.09% |
Analyst Forecast
The average price target for MiMedx Group is $12.00, which is 29.87% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.00 |
Price Target Difference | 29.87% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 11.94% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MiMedx Group has an Altman Z-Score of 11.61 and a Piotroski F-Score of 6.
Altman Z-Score | 11.61 |
Piotroski F-Score | 6 |